Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAHOR for Hypercholesterolaemia: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 11 adverse event reports in the FDA FAERS database where TAHOR was used for Hypercholesterolaemia.

Most Reported Side Effects for TAHOR

Side Effect Reports % Deaths Hosp.
Hepatocellular injury 11 8.9% 0 8
Rhabdomyolysis 11 8.9% 2 10
Cholestasis 9 7.3% 0 5
Renal failure 8 6.5% 1 7
Thrombocytopenia 8 6.5% 4 6
Drug reaction with eosinophilia and systemic symptoms 6 4.8% 0 6
Inflammation 6 4.8% 0 3
Lung disorder 6 4.8% 3 6
Pancytopenia 6 4.8% 0 6
Weight decreased 6 4.8% 0 1
Abdominal pain upper 5 4.0% 0 4
Diarrhoea 5 4.0% 0 1
Interstitial lung disease 5 4.0% 2 4

Other Indications for TAHOR

Product used for unknown indication (31) Dyslipidaemia (12)

Other Drugs Used for Hypercholesterolaemia

EVOLOCUMAB (23,505) ATORVASTATIN (5,615) ALIROCUMAB (4,924) SIMVASTATIN (3,010) ROSUVASTATIN (2,690) EZETIMIBE (1,589) PRAVASTATIN (764) INCLISIRAN (486) FENOFIBRATE (286) FLUVASTATIN (264)

Related Pages

TAHOR Full Profile All Hypercholesterolaemia Drugs TAHOR Demographics TAHOR Timeline